tranexamic acid has been researched along with Myocarditis in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritsch, N | 1 |
| Pouquet, O | 1 |
| Roux, B | 1 |
| Abdelmoumen, Y | 1 |
| Janvier, G | 1 |
1 other study available for tranexamic acid and Myocarditis
| Article | Year |
|---|---|
[Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
Topics: Adult; Anticoagulants; Aprotinin; Blood Transfusion; Blood Transfusion, Autologous; Cardiac Tamponad | 2010 |